SAGCX
Price
$132.17
Change
-$0.30 (-0.23%)
Updated
Jun 2 closing price
Net Assets
4.25B
VTSAX
Price
$182.18
Change
+$0.43 (+0.24%)
Updated
Jun 2 closing price
Net Assets
2.2T
Interact to see
Advertisement

SAGCX vs VTSAX

Header iconSAGCX vs VTSAX Comparison
Open Charts SAGCX vs VTSAXBanner chart's image
SAGCX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
SAGCX vs. VTSAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAGCX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.2T vs. SAGCX (4.25B). VTSAX pays higher dividends than SAGCX: VTSAX (1.00) vs SAGCX (0.00). SAGCX was incepted earlier than VTSAX: SAGCX (33 years) vs VTSAX (26 years). SAGCX (1.86) is less costly to investors than VTSAX (0.04). SAGCX is a more actively managed with annual turnover of: 26.00 vs. VTSAX (3.00). SAGCX has a lower initial minimum investment than VTSAX: SAGCX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 28.25 vs. SAGCX (-75.74). VTSAX return over 5 years is better than : 72.43 vs. SAGCX (-93.53).
SAGCXVTSAXSAGCX / VTSAX
Total Expense Ratio1.860.044,650%
Annual Report Gross Expense Ratio1.860.044,650%
Fund Existence33 years26 years-
Gain YTD3.79211.38833%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.25B2.2T0%
Annual Yield % from dividends0.001.00-
Returns for 1 year-75.7428.25-268%
Returns for 3 years-84.8376.03-112%
Returns for 5 years-93.5372.43-129%
Returns for 10 years-94.64260.72-36%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEF63.461.06
+1.70%
Greif
SWBI15.310.17
+1.12%
Smith & Wesson Brands
GHG1.25-0.01
-0.79%
GreenTree Hospitality Group Ltd
WST312.17-4.13
-1.31%
West Pharmaceutical Services
CANF3.11-0.13
-4.01%
Can-Fite Biopharma Ltd